Real-time commercial impact of clinical data from every major oncology congress

Access Reports

Syndicated IMPACT Analysis
Rapid Impact ReportsTM

Rapid Impact Reports analyze and measure the commercial impact of tumor-specific clinical trial data at every major oncology congress

SHOP REPORTS >>

Impact
Custom IMPACT AnalysisTM

Custom reports that analyze and measure the commercial impact of business-critical clinical trial data on your business

LEARN MORE >>

Custom INTELLIGENCETM

Custom qualitative and quantitative market research

LEARN MORE >>

What’s the commercial impact of business-critical clinical trial data?

The insights you have been looking for are now available at the click of a button. Shop reports to see our latest Rapid Impact Reports. Don’t see your important data covered in our Rapid Impact Reports? Contact us and we will develop a customized analysis.

Learn More

Testimonial Icon
Rapid Impact Report

After every major congress, a deck shows up in my inbox that helps me understand how newly released data are going to impact oncologists’ behaviors. The executive summary, charts, graphs and quotes are very helpful for my team and me.

-Snr. Director of Marketing, Oncology

Testimonial Icon
Custom INTELLIGENCETM

Breaking Data helped us discover and understand business-critical insights from IDN decision-makers. Their research and deliverable helped us obtain buy-in from the head of North America so we could move our pilot to the next phase.

-Head of Managed Markets Strategy

Testimonial Icon
Custom IMPACT AnalysisTM

We needed to better understand the “post-congress” commercial impact of data for a specific tumor. Breaking Data’s customized approach answered all of our critical questions, and then some.

-Associate Director, Competitive Intelligence, Solid Tumor

Testimonial Icon
Custom IMPACT AnalysisTM

Immediately after the abstracts are available online, Breaking Data helps us identify what’s important and why. From there, our questions emerge. And those questions are answered by their panel of oncologists who attend the congress.

-Director of Market Research, Oncology

Testimonial Icon
Custom INTELLIGENCETM

We were tasked with building a go-to-market strategy for a novel immunotherapy. We chose Breaking Data because they walked in in our shoes before. They had the “hands-on” experience that we needed. Our collaboration resulted in a research framework that answered our core questions.

-US Pre-Commercialization Lead, Hematology